Stocks to sell

AMC Entertainment (NYSE:AMC) stock has faced both negative and positive developments. A notable investment fund has sold its entire stake, but an analyst sees growth potential driven by expected box-office revenues. The theater chain continues to see outsized attention from meme-stock traders, leading to interest among retail investors. However, despite AMC’s apparent recovery, this meme
0 Comments
The strength of growth stocks continues in 2023, with the Nasdaq 100 index approaching its previous high from November 2021. It’s the strongest first half on record for the exchange, reflecting a healthy economy with significant growth and receding inflation. But that’s really not the case with the stocks listed below. The stock market rally
0 Comments
Recent months have brought struggle to many well-known, blue-chip stocks as the broader market has been lifted higher. This is disappointing, especially as many of the biggest under-performers are stocks that have traditionally been long-term winners for investors. And yet, many previously reliable blue-chips are lagging the expanded market. For them, poor performance is due
0 Comments
In the realm of investing, penny stocks can be misleading with their low price tags. It’s important to understand that a low price doesn’t always equate to a high upside. Therefore, knowing which penny stocks to sell is crucial in today’s market, with many of these stocks carrying inflated valuations, making their potential returns highly
0 Comments
The travel and tourism industry continues to recover following the devastating blow of the coronavirus pandemic in 2020. The U.S. travel sector has taken off again, but the journey toward stock-price recovery is still filled with turbulence. Nevertheless, it’s imperative to separate the wheat from the chaff and avoid a long list of doomed travel
0 Comments
The world of biotech stocks is notoriously difficult to predict. History is littered with companies that appeared destined for superstar status only to crash and burn. A brutal FDA approval process is partly responsible for that truth. 90% of clinical drug development leads to failure. Developmental costs are another important factor.  High failure combined with
0 Comments
Although acquiring shares of companies listed in the Dow Jones Industrial Average tends to be a smart wager, shifting economic circumstances might raise a cloud of suspicion over certain doomed Dow stocks to avoid. To be 100% clear, this list represents a mental exercise based on forward circumstances that may or may not materialize. It’s
0 Comments
While passive income typically represents a solid goal for most investors, the below doomed dividend stocks to avoid confirm that there’s no such thing as a risk-free sector. It’s like buying a used car. In arguably most circumstances, going the secondhand route is smart because it saves you money. However, you must do your homework.
0 Comments